- Home
- SOPH vs SABA Comparison
SOPH vs SABA Comparison
Compare SOPH & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SOPH | SABA |
|---|---|---|
| Founded | 2011 | 1988 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 330.4M | 240.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SOPH | SABA |
|---|---|---|
| Price | $4.74 | $8.43 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 75.4K | ★ 290.0K |
| Earning Date | 11-04-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.91% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $73,297,000.00 | N/A |
| Revenue This Year | $18.32 | N/A |
| Revenue Next Year | $15.61 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 13.66 | N/A |
| 52 Week Low | $2.58 | $3.64 |
| 52 Week High | $5.30 | $4.42 |
Technical Indicators
Market Signals| Indicator | SOPH | SABA |
|---|---|---|
| Relative Strength Index (RSI) | 52.12 | 33.95 |
| Support Level | $4.50 | $8.35 |
| Resistance Level | $4.84 | $8.79 |
| Average True Range (ATR) | 0.22 | 0.10 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 48.00 | 18.19 |
Price Performance
Historical ComparisonAbout SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Saba Capital Income & Opportunities Fund II is a closed-end fund. The company seeks high current income, with a secondary goal of capital appreciation. The fund invests in fixed income markets across the globe.